Home
Email:
Password:
Forget your password?
David Pieroni, Managing Director of Automation Quality Solutions (AQS)
More podcasts
Monday, February 8, 2010
Rough tender treatment- New gov't regs may try to relieve drug bidding strains
Free access
Essential drug tendering putting pressure on health system
There will be blood... Shenzhen Guangming plans new plasma product facility
Free access
Government advocates customer service focus at hospitals
Guizhou Yibai signs acquisition deal for Yunnan Nanzhao
MOH releases 2010 China National Formulary
Friday, February 5, 2010
China drug import/export stats for 2009 released, US top pharma trading partner
Sichuan Kelun Pharmaceutical seeks CSRC IPO approval
Thursday, February 4, 2010
State Council passed hospital reform guidance, re-affirms 5 top goals
Big-picture 2009 healthcare stats released- spending up, still less than 5% GDP
Commercial insurers find role in government health insurance programs
2009 OTC winners announced- Xiuzheng, Xian-Janssen take top slots
China Global Fund AIDS project gets underway in Guangxi
Wednesday, February 3, 2010
SFDA outlines major food and drug inspection goals for 2010
2010 Pharmacopoeia to be released soon, implemented by summer
Summary stats released in aftermath of Guangdong centralized drug tendering
Free access
Bottoms up business approach: Tongjitang buys liquor factory
Free access
Recent survey shows rising breast cancer rates in urban areas
Tuesday, February 2, 2010
Essential drug twist- gov't feels EDL zero markup squeeze, seeks other funding
Free access
Response Biomed signs 2nd partnership in China, will ramp up diagnostic sales
SPG digests recent acquisitions but still hungry for more, will keep name
Free access
Hunan releases provincial essential drug price list
Hisun buys stake in Kanghong Sagent Pharma US parent
Monday, February 1, 2010
Covance to establish preclinical facility near Shanghai
Sanofi-Aventis/Hangzhou Minsheng JV to focus on supplements, OTC products
About us
|
Contact us
|
FAQ
|
Feedback
© GB Group limited. All right reserved.
pharmaceutical,china pharmaceutical,pharm,pharmhound,generalbiologic,China drug,Drug discovery,Pharmaceutical market,China Antibody,China preclinical,China clinical trial,China CRO,China API,Matthew Chervenak,China research and development,China hepatitis,China cancer,China diabetes,China oncology,China cardiovascular,China CNS,China disease